Australia's largest stock trading and investment forum Australia's #1 stock forum

SDL

0.00%

0.6¢ sundance resources limited

Hey Westcott, page-45

First 45 Last

Share
Profile

Follow
westcott

8,602 Posts.

40

23/02/15

10:32

Post #: 14800434
Share

Originally posted by squidd ↑

Hi westcott,

"If worker numbers are cut back, they would hardly be chewing through its cash flow as you are implying. Spending cash at a slower rate I would think. Simple to work that out I would have thought."

A quick glance at the recent quarterly cash flow report would show the company plans on still chewing through cash.

The rate of cash burn is slower after the lay offs, but it's still $8m+ per quarter for a company with no cashfl0ws and probably only ~$25m in the bank as of now.

This is not me implying anything, it's not hard to read the quarterly cash flow reports and extrapolate. That's how I called the last two CR's that seemed to blindside so many holders.

I'm sad to say it feels like your just arguing for arguments sake now westcott. What level headed, realistic person following SDL wouldn't think cash burn was a serious issue...

Good luck!

Expand

Hi Squidd.

Any level headed person would not need to be reminded all the time by you that of course there will be a need for further cash raising if they don't keep to time lines they have announced. Did I not say I have asked them several times to give realistic time lines for future events to happen?
Any idiot can be assured they will still be spending cash, not hard to see that.

Regards
Westcott.

SDL Price at posting: 2.4¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally